Skip to main content
Premium Trial:

Request an Annual Quote

RevoluGen Signs Taiwan Distribution Deal for DNA Extraction Product

NEW YORK — UK reagent firm RevoluGen said on Monday that it has signed a deal with Welgene Biotech to distribute its Fire Monkey/Fire Flower High Molecular Weight DNA (HMW-DNA) extraction and purification product in Taiwan.

Under the terms of the deal, Taipei City-based Welgene has the nonexclusive right to promote, market, and sell RevoluGen's product to its molecular biology customers in Taiwan. Additional terms were not disclosed.

Fire Monkey/Fire Flower uses spin columns to extract HMW-DNA with an average length of 100 kb or more from animal and bacterial cells, followed by the removal of DNA fragments smaller than 10 kb, according to RevoluGen.

Earlier this year, RevoluGen signed a nonexclusive manufacturing deal for Fire Monkey/Fire Flower with GE Healthcare Life Sciences, and last year, it signed a nonexclusive worldwide distribution agreement for the product with Merck KGaA.



The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.